| 1 |
High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts. ( 29402726
)
|
Wang J....Jin J.
|
2018 |
| 2 |
Mutation profile and associated clinical features in Chinese patients with cytogenetically normal acute myeloid leukemia. ( 29573577
)
|
Wang S....Chen B.
|
2018 |
| 3 |
Up-regulation of regulatory T cells, CD200 and TIM3 expression in cytogenetically normal acute myeloid leukemia. ( 29843224
)
|
Zahran A.M....Hetta H.F.
|
2018 |
| 4 |
Successful Treatment of Cytogenetically Normal Acute Myeloid Leukemia With Ten-Eleven Translocation 2-Isocitrate Dehydrogenase 2 and Additional Sex Comb-like 1-Nucleophosmin Co-mutations by HLA Haploidentical Stem Cell Transplantation: A Case Report and Literature Review. ( 29661468
)
|
Liu Y....Gu W.Y.
|
2018 |
| 5 |
Lower expression of bone marrow miR-122 is an independent risk factor for overall survival in cytogenetically normal acute myeloid leukemia. ( 29627222
)
|
Zhang T.J....Qian J.
|
2018 |
| 6 |
Residual disease detection using targeted parallel sequencing predicts relapse in cytogenetically normal acute myeloid leukemia. ( 28960408
)
|
Gaksch L....WAPlfler A.
|
2018 |
| 7 |
Evolution of cytogenetically normal acute myeloid leukemia during therapy and relapse: An exome sequencing study of 50 patients. ( 29330206
)
|
Greif P.A....Spiekermann K.
|
2018 |
| 8 |
MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia. ( 29540187
)
|
Ma Q.L....Jin J.
|
2018 |
| 9 |
A novel type of NPM1 mutation characterized by multiple internal tandem repeats in a case of cytogenetically normal acute myeloid leukemia. ( 29903763
)
|
Duployez N....Preudhomme C.
|
2018 |
| 10 |
Low NKD1 expression predicts adverse prognosis in cytogenetically normal acute myeloid leukemia. ( 28443469
)
|
Zhou J.D....Qian J.
|
2017 |
| 11 |
<i>KRAS</i> overexpression independent of<i>RAS</i>mutations confers an adverse prognosis in cytogenetically normal acute myeloid leukemia. ( 29029494
)
|
Zhou J.D....Qian J.
|
2017 |
| 12 |
Long non-coding RNA expression profile in cytogenetically normal acute myeloid leukemia identifies a distinct signature and a new biomarker in NPM1-mutated patients. ( 28679652
)
|
De Clara E....Bousquet M.
|
2017 |
| 13 |
Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemia. ( 28473620
)
|
Papaioannou D....Bloomfield C.D.
|
2017 |
| 14 |
High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients. ( 28407515
)
|
Tiribelli M....Damiani D.
|
2017 |
| 15 |
A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia. ( 28473658
)
|
Zhu R....Hu Y.
|
2017 |
| 16 |
E-26 Transformation-specific Related Gene Expression and Outcomes in Cytogenetically Normal Acute Myeloid Leukemia: A Meta-analysis. ( 28584213
)
|
Fang J.F....Wang X.J.
|
2017 |
| 17 |
TET2 expression is a potential prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia. ( 29219176
)
|
Zhang T.J....Qian J.
|
2017 |
| 18 |
Impact of fludarabine-based induction therapy on outcome of FLT3-/NPM1+ cytogenetically normal acute myeloid leukemia. ( 28076884
)
|
Tiribelli M....Damiani D.
|
2017 |
| 19 |
Gene and protein analysis reveals that p53 pathway is functionally inactivated in cytogenetically normal Acute Myeloid Leukemia and Acute Promyelocytic Leukemia. ( 28340577
)
|
Abramowitz J....Ben-Yehuda D.
|
2017 |
| 20 |
Molecular Mutations and Their Cooccurrences in Cytogenetically Normal Acute Myeloid Leukemia. ( 28197208
)
|
Wang M....Schaar D.G.
|
2017 |
| 21 |
Phe354Leu Polymorphism of LKB1 Is a Potential Prognostic Factor for Cytogenetically Normal Acute Myeloid Leukemia. ( 28882949
)
|
Yang M.Y....Lin P.M.
|
2017 |
| 22 |
Association of a cytarabine chemosensitivity related gene expression signature with survival in cytogenetically normal acute myeloid leukemia. ( 27903973
)
|
Yan H....Chen X.P.
|
2016 |
| 23 |
TIGAR cooperated with glycolysis to inhibit the apoptosis of leukemia cells and associated with poor prognosis in patients with cytogenetically normal acute myeloid leukemia. ( 27884166
)
|
Qian S....Chen Y.
|
2016 |
| 24 |
Persistent DNMT3A mutation burden in DNMT3A mutated adult cytogenetically normal acute myeloid leukemia patients in long-term remission. ( 27626217
)
|
Sun Y....Xu Y.
|
2016 |
| 25 |
The effect of FLT3-ITD and NPM1 mutation on survival in intensively treated elderly patients with cytogenetically normal acute myeloid leukemia - Response to Rashidi etA al. ( 27090743
)
|
McGregor A.K....Jones G.
|
2016 |
| 26 |
The effect of FLT3-ITD and NPM1 mutation on survival in intensively treated elderly patients with cytogenetically normal acute myeloid leukemia. ( 27003236
)
|
Rashidi A....Chen Y.B.
|
2016 |
| 27 |
High expression of RUNX1 is associated with poorer outcomes in cytogenetically normal acute myeloid leukemia. ( 26910834
)
|
Fu L....Ke X.
|
2016 |
| 28 |
High expression of MAP7 predicts adverse prognosis in young patients with cytogenetically normal acute myeloid leukemia. ( 27686215
)
|
Fu L....Shi J.
|
2016 |
| 29 |
Mitogen-activated protein kinase binding protein 1 (MAPKBP1) is an unfavorable prognostic biomarker in cytogenetically normal acute myeloid leukemia. ( 25924238
)
|
Fu L....Ke X.
|
2015 |
| 30 |
Deregulation of miR-1, miR486, and let-7a in cytogenetically normal acute myeloid leukemia: association with NPM1 and FLT3 mutation and clinical characteristics. ( 26526573
)
|
Seyyedi S.S....Akrami S.M.
|
2015 |
| 31 |
Immunological markers for prognostication in cytogenetically normal acute myeloid leukemia. ( 26317398
)
|
Ling V.Y....Ting S.B.
|
2015 |
| 32 |
Identification of the NUP98-PHF23 fusion gene in pediatric cytogenetically normal acute myeloid leukemia by whole-transcriptome sequencing. ( 26066811
)
|
Togni M....Locatelli F.
|
2015 |
| 33 |
Overexpression of ATP1B1 predicts an adverse prognosis in cytogenetically normal acute myeloid leukemia. ( 26506237
)
|
Shi J.L....Wang W.D.
|
2015 |
| 34 |
Impact of genomics in the clinical management of patients with cytogenetically normal acute myeloid leukemia. ( 26590764
)
|
Falini B....Martelli M.P.
|
2015 |
| 35 |
Prevalence and Clinical Effect of IDH1 and IDH2 Mutations Among Cytogenetically Normal Acute Myeloid Leukemia Patients. ( 26189213
)
|
Aref S....Zeid T.A.
|
2015 |
| 36 |
Residual Disease in a Novel Xenograft Model of RUNX1-Mutated, Cytogenetically Normal Acute Myeloid Leukemia. ( 26177509
)
|
Sivagnanalingam U....Mendler J.H.
|
2015 |
| 37 |
Identification of let-7a-2-3p or/and miR-188-5p as prognostic biomarkers in cytogenetically normal acute myeloid leukemia. ( 25646775
)
|
Jinlong S....Weidong W.
|
2015 |
| 38 |
High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia. ( 25779662
)
|
Shi J.L....Wang W.D.
|
2015 |
| 39 |
TET2 gene mutation is unfavorable prognostic factor in cytogenetically normal acute myeloid leukemia patients with NPM1+ and FLT3-ITD - mutations. ( 24859829
)
|
Tian X....Sun A.
|
2014 |
| 40 |
Impact of additional genetic alterations on the outcome of patients with NPM1-mutated cytogenetically normal acute myeloid leukemia. ( 25552703
)
|
Peterlin P....Dombret H.
|
2014 |
| 41 |
DNMT3A R882 mutations in patients with cytogenetically normal acute myeloid leukemia and myelodysplastic syndrome. ( 24512939
)
|
El Ghannam D....Eneen A.F.
|
2014 |
| 42 |
Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemia. ( 24711548
)
|
Pastore F....Hoster E.
|
2014 |
| 43 |
NPM1 gene mutation in Egyptian patients with cytogenetically normal acute myeloid leukemia. ( 25648021
)
|
Sofan M.A....Bazid M.M.
|
2014 |
| 44 |
BAALC expression: a suitable marker for prognostic risk stratification and detection of residual disease in cytogenetically normal acute myeloid leukemia. ( 24413067
)
|
Weber S....Schnittger S.
|
2014 |
| 45 |
Cytogenetically Normal Acute Myeloid Leukemia with a Novel KIT Mutation in Exon 11 G565V Developing a Sole Trisomy 13 at Relapse: A Clinical Dilemma. ( 24968822
)
|
Nieto M.J....Najfeld V.
|
2014 |
| 46 |
Wilms tumor 1 gene mutations in patients with cytogenetically normal acute myeloid leukemia. ( 25035671
)
|
Aref S....Menshawy N.E.
|
2014 |
| 47 |
Prognostic relevance of Wilms tumor 1 (WT1) gene Exon 7 mutations in-patient with cytogenetically normal acute myeloid leukemia. ( 25435718
)
|
Aref S....Raouf D.A.
|
2014 |
| 48 |
TET2 mutations in cytogenetically normal acute myeloid leukemia: clinical implications and evolutionary patterns. ( 24898826
)
|
Damm F....Ganser A.
|
2014 |
| 49 |
Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia. ( 23540998
)
|
Shamaa S....Taalab M.M.
|
2014 |
| 50 |
A gene expression profile associated with relapse of cytogenetically normal acute myeloid leukemia is enriched for leukemia stem cell genes. ( 25030037
)
|
Hackl H....Wieser R.
|
2014 |
